Skip to content
Science helped save the world from COVID. What will vaccine technology do next? Today’s new episode of the I am BIO Podcast explores this […]
I am BIO Podcast: What will COVID vaccine technology do next? Read More »
The pandemic showed us that we can develop vaccines and other drugs in a short time, and get a lot of people vaccinated, but
POLITICO’s Health Care Summit: The Many Legacies of COVID Read More »
We need to use the lessons from the COVID-19 to improve our supply chain preparedness for the next pandemic, Phyllis Arthur, the Vice President
Watch: BIO’s Phyllis Arthur on supply chains and pandemic prep Read More »
A new federal research agency would seek solutions for the most challenging diseases, clinical trials would become more diverse, and patients would get new
The Cures 2.0 bill: ‘Frankly, patients can’t wait’ Read More »
Pfizer and Moderna are both requesting Food and Drug Administration (FDA) emergency use authorization for a second booster shot of their mRNA vaccines against
Moderna and Pfizer ask FDA to OK more boosters Read More »
The Biotechnology Innovation Organization (BIO) launched a new season of the I am BIO Podcast on March 22, 2022, with an episode for World
I am BIO Podcast: Water Stress: Can We Avert a Looming Crisis? Read More »
A recent letter to U.S. Health and Human Services Secretary Xavier Becerra explains why a petition asking the government to “march in” on a
100 experts urge HHS to reject Bayh-Dole ‘march-in’ petition Read More »
Legislation to modernize the clinical drug development paradigm should be patient-centric, effective and inclusive, Biotechnology Innovation Organization (BIO) Chief Scientific Officer Dr. Cartier Esham
BIO’s CSO testifies at congressional hearing on PDUFA riders Read More »
The United States, European Union, India, and South Africa “reached a consensus on key elements of a long-sought intellectual property waiver for COVID-19 vaccines,”
Agreement reported on waiver of COVID vaccine IP protections Read More »
Bacterial and fungal infections that follow on the back of SARS-CoV-2 coronavirus have forced doctors to increase the use of antibiotics and antifungal medications,
Squash Superbugs Day of Action to address medical and market challenges of AMR Read More »
